(6) Therapeutic efficacy is highly time sensitive, with optimal outcomes occurring prior to completion of the aging process and markedly reduced oxime responsiveness after the post-aging window
"Deca" means ten
Development and FDA Approval The development of Sermorelin arose from research in the 1970s-1980s that characterized GHRH structure, function, and identified that the biologically active portion responsible for GH-releasing activity resides in the N-terminal region of the molecule, specifically amino acids 1-29, while the C-terminal portion (amino acids 30-44) is not required for receptor binding or signaling
Knudsen LB, Nielsen PF, Huusfeldt PO, Johansen NL, Madsen K, Pedersen FZ, Thgersen H, Wilken M, Agers H
Nutritional guidance from a functional nutritionist to help maintain results
Provider Led Real provider-led care with monthly follow-ups Prescription Meds GLP-1s & oral appetite suppressants prescribed safely Tracking Styku scan to track progress beyond the scale Nutrition Personalized nutrition & diet recommendations Accountability Ongoing messaging with your provider Made for You No cookie-cutter plans